Refine
Has Fulltext
- yes (17)
Is part of the Bibliography
- yes (17)
Document Type
- Journal article (16)
- Doctoral Thesis (1)
Keywords
- COVID-19 (3)
- Neisseria meningitidis (2)
- acute respiratory distress syndrome (2)
- critical care (2)
- inflammation (2)
- oxidative stress (2)
- ARDS (acute respiratory distress syndrome) (1)
- Alzheimer’s disease (1)
- C5aR1 (1)
- C5aR1-Antagonist (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (12)
- Institut für Klinische Epidemiologie und Biometrie (4)
- Medizinische Klinik und Poliklinik I (4)
- Frauenklinik und Poliklinik (2)
- Institut für Hygiene und Mikrobiologie (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Medizinische Klinik und Poliklinik II (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Graduate School of Life Sciences (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Klinische Neurobiologie (1)
- Institut für Psychologie (1)
- Institut für Psychotherapie und Medizinische Psychologie (1)
- Institut für Virologie und Immunbiologie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Medizinische Fakultät (1)
- Neurochirurgische Klinik und Poliklinik (1)
- Neurologische Klinik und Poliklinik (1)
Background
The viral load and tissue distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain important questions. The current study investigated SARS-CoV-2 viral load, biodistribution and anti-SARS-CoV-2 antibody formation in patients suffering from severe corona virus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS).
Methods
This is a retrospective single-center study in 23 patients with COVID-19-induced ARDS. Data were collected within routine intensive care. SARS-CoV-2 viral load was assessed via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Overall, 478 virology samples were taken. Anti-SARS-CoV-2-Spike-receptor binding domain (RBD) antibody detection of blood samples was performed with an enzyme-linked immunosorbent assay.
Results
Most patients (91%) suffered from severe ARDS during ICU treatment with a 30-day mortality of 30%. None of the patients received antiviral treatment. Tracheal aspirates tested positive for SARS-CoV-2 in 100% of the cases, oropharyngeal swabs only in 77%. Blood samples were positive in 26% of the patients. No difference of viral load was found in tracheal or blood samples with regard to 30-day survival or disease severity. SARS-CoV-2 was never found in dialysate. Serologic testing revealed significantly lower concentrations of SARS-CoV-2 neutralizing IgM and IgA antibodies in survivors compared to non-survivors (p = 0.009).
Conclusions
COVID-19 induced ARDS is accompanied by a high viral load of SARS-CoV-2 in tracheal aspirates, which remained detectable in the majority throughout intensive care treatment. Remarkably, SARS-CoV-2 RNA was never detected in dialysate even in patients with RNAemia. Viral load or the buildup of neutralizing antibodies was not associated with 30-day survival or disease severity.